Latest

Explore our selection of research articles and news

Launching the Seerave Global Oncobiome Atlas

Launching the Seerave Global Oncobiome Atlas

Jun / 2025

Launching the Seerave Global Oncobiome Atlas

Launching the Seerave Global Oncobiome Atlas

Jun / 2025

The Microbiome and Immuno-oncology in the Spotlight at ASCO 2025

Network
The Microbiome and Immuno-oncology in the Spotlight at ASCO 2025

May / 2025

Dispatch from Seerave Retreat 2024

Seerave Community
Dispatch from Seerave Retreat 2024

Nov / 2024

Seerave invests in Florey Biosciences and takes aim at mitigating impacts of antibiotic use

Seerave Publication
Seerave invests in Florey Biosciences and takes aim at mitigating impacts of antibiotic use

Oct / 2024

Seerave Announces Strategic Focus on Antibiotics and Cancer Immunotherapy

Seerave Publication
Seerave Announces Strategic Focus on Antibiotics and Cancer Immunotherapy

Jul / 2024

Funder Impact Roundtable

Seerave Translational
Funder Impact Roundtable

Feb / 2024

Longitudinal PRIMM Data published in Nature Medicine

Seerave Publication
Longitudinal PRIMM Data published in Nature Medicine

Feb / 2024

New Perspective Paper Published in Cancer Cell on Melanoma and Microbiota

Seerave Publication
New Perspective Paper Published in Cancer Cell on Melanoma and Microbiota

Jan / 2024

New collaboration established with the Cancer Platform

Translation
New collaboration established with the Cancer Platform

Sep / 2023

Seerave supports the Microbiome Virtual International Forum

Network
Seerave supports the Microbiome Virtual International Forum

Aug / 2023

The Invisible Extinction – Amsterdam Screening

Translational
The Invisible Extinction – Amsterdam Screening

Jun / 2023

Seerave Retreat 2023

Seerave Community
Seerave Retreat 2023

Jun / 2023